Glaucoma - Are You at Risk?

 

January 22, 2007  |  

Approximately 2.2 million Americans age 40 and older have glaucoma, and half of those are at risk for going blind because they do not know they have the disease. 

Glaucoma is a condition in which the optic nerve, responsible for transmitting visual information from the eye to the brain, is damaged.  Although the nerve damage is usually associated with elevated pressure inside the eye, other factors can be involved.  It may begin with the loss of peripheral vision and then advance to a reduction in central vision.  Glaucoma can potentially lead to vision loss or blindness.

“Most people who have glaucoma don’t notice symptoms until they begin to lose some vision.  But vision loss from glaucoma can be prevented if it’s detected and treated in time,” said Robert N. Weinreb, M.D., Distinguished Professor of Ophthalmology and Director of the Hamilton Glaucoma Center at the University of California, San Diego.  Weinreb is also President of the American Glaucoma Society.  “As part of Glaucoma Awareness Month in January, we urge everyone at risk of developing glaucoma to get a complete eye exam.”

So, who’s at risk? “People with a family history of glaucoma, all individuals over age 60, African-Americans over age 40, Hispanics, and people with other health conditions, such as diabetes and those who have experienced a serious eye injury are considered at risk,” says Dr. Weinreb.  He recommends that anyone who falls into one or more of those categories should talk with an eye doctor about how often an eye examination should be conducted to ensure good vision.

Although glaucoma cannot be cured, early detection and treatment can usually preserve vision.  Knowing the risk factors and having a regular eye examination can help ensure early detection and improved management of the disease.

Media Contact:  Health Sciences Communications. 619-543-6163


Related Specialties



Media Contact

Share This Article


Related News

2/15/2019
The Next Generation Precision Oncology Symposium, a novel meeting of industry and academic leaders in cancer science and medicine, will be held February 21, 2019 at UC San Diego Moores Cancer Center.
2/14/2019
Researchers at UC San Diego School of Medicine report that persons with schizophrenia scored lower on a wisdom assessment than non-psychiatric comparison participants, but that there was considerable ...
2/13/2019
In a randomized, controlled pilot trial published February 13, 2019 in PLOS ONE, UC San Diego School of Medicine researchers found that participants pre-treated with noninvasive vagus nerve stimulatio ...
2/12/2019
In a new study, researchers at University of California San Diego School of Medicine report that hearing impairment is associated with accelerated cognitive decline with age, though the impact of mild ...



Follow Us